---
category: news
title: "New Alzheimer's drug slows cognitive decline, clinical trial finds"
excerpt: "The companies announced the trial's success in a press release Tuesday, saying that cognitive decline slowed 27% in patients using their drug — called lecanemab — over 18 months compared with ..."
publishedDateTime: 2022-09-26T23:59:00Z
originalUrl: "https://www.businessinsider.com/clinical-trial-finds-new-alzheimers-drug-slows-cognitive-decline-2022-9"
webUrl: "https://www.businessinsider.com/clinical-trial-finds-new-alzheimers-drug-slows-cognitive-decline-2022-9"
ampWebUrl: "https://www.businessinsider.com/clinical-trial-finds-new-alzheimers-drug-slows-cognitive-decline-2022-9?amp"
cdnAmpWebUrl: "https://www-businessinsider-com.cdn.ampproject.org/c/s/www.businessinsider.com/clinical-trial-finds-new-alzheimers-drug-slows-cognitive-decline-2022-9?amp"
type: article

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - Microsoft AI
  - AI

images:
  - url: "https://i.insider.com/6333afdd9ac0610018e7fc4e?width=1200&format=jpeg"
    width: 1200
    height: 600
    isCached: true

secured: "DZrEQbRlNbcoK2xF3fZ7lsn14jZaxmr7I3c0TiZucr0yv0isMmbpr9LS4FEA01lWYclE9kj5cxs1e9R4Plp5W3nZ+/j+4I0mK+e7QLC5mhXjExxPz6ptQwyJChgxhrLoa1ORw1foZIf32XM7WiDeV+4fuoH8E5G7bDu5k4mPciQfq5fH2YatP9123LtIoBGNGem9XaJKUD0wMxrWtHgIJ9xP5G4OBGgqsfzGoW9h0bq6zF66y+4Mqe8lf8xGdkuCNeNWuYYrtjl7HYNibEAQdgkMoQjk6fDI/ypF8+7qNCRdmOXK5mE7a9PCgzqNXDoihAZEJmCJxlsn6+tikzgTxZBoqDQW96QT5dL0QOptYDw=;fKo0CWcjf14SHWTeRaKcWA=="
---

